At Riomedica Healthcare Pvt. Ltd., therapeutic efficacy and patient safety form the cornerstone of every formulation. Our portfolio of 700+ medicines complies with rigorous WHO-GMP, ISO 9001:2015, and CDSCO standards, backed by batch-by-batch Certificate of Analysis (COA) testing.
Doctors, pharmacists, and institutional buyers can request official Certificate of Analysis verification.
Comprehensive testing at every step from raw molecule testing to final patient packaging guarantees unwavering therapeutic efficacy.
Every active pharmaceutical ingredient (API) and functional excipient undergoes rigorous identity and purity validation before entering formulation batches.
Continuous monitoring during granulation, compression, and coating prevents batch variations and guarantees uniform dosage delivery.
Advanced analytical chromatography verifies that each tablet, capsule, or vial contains exactly 100% of the declared therapeutic dose.
Zero tolerance for microbial contamination across injectables, oral liquids, eye drops, and dry powder formulations.
Superior packaging engineering safeguards the molecular stability of sensitive medicines throughout Indian tropical conditions.
No consignment leaves the warehouse without a formal Certificate of Analysis authorized by our Qualified Quality Assurance Managers.
Our operational and clinical procedures comply with the statutory guidelines mandated by drug regulatory authorities.
World Health Organization Good Manufacturing Practices ensuring state-of-the-art facilities and cleanliness.
Internationally audited Quality Management System governing every business and logistical interaction.
All 700+ formulations are formally sanctioned by the Central Drugs Standard Control Organisation (CDSCO).
Good Laboratory Practices adhering to calibrated analytical instruments and standardized test protocols.
Transparency in raw materials, stability testing, and regulatory documentation.
